NCT03680378View on ClinicalTrials.gov

Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Healthy Subjects
Interventions
DRUG

Cefepime 2 gram

Combination of cefepime 2 gram with AAI101 1 gram

Trial Locations (1)

L69 3GL

University of Liverpool, Liverpool

Sponsors

Lead Sponsor

Allecra
All Listed Sponsors
lead

Allecra

INDUSTRY

NCT03680378 - Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF) | Biotech Hunter | Biotech Hunter